Siplizumab (MEDI-507) is actually a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative growth of alloreactive regulatory T cells in...
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext, image
ImageAI Generated
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/939501f1-239d-4605-a129-bdbcca717dfc)